Sign in
4

Changes in Ownership

PRECISION BIOSCIENCES INC Filed Acc 0001209191-23-054546

Chief Financial Officer acquired 108,188 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kelly John Alexander Chief Financial Officer 2023-11-02 Option exercise +108,188 497,479 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Kelly John Alexander Chief Financial Officer 2023-11-02 Option exercise · Restricted Stock Units −108,188 216,312 D: show line 2 in the form
Loading xslF345X05/doc4.xml…